Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
van der Lee, Conway, Jansen, Carrasquillo, Kleineidam, van den Akker, Hernández, van Eijk, Stringa, Chen, Zettergren, Andlauer, Diez-Fairen, Simon-Sanchez, Lleó, Zetterberg, Nygaard, Blauwendraat, Savage, Mengel-From, Moreno-Grau, Wagner, Fortea, Keogh, Blennow, Skoog, Friese, Pletnikova, Zulaica, Lage, de Rojas, Riedel-Heller, Illán-Gala, Wei, Jeune, Orellana, Then Bergh, Wang, Hulsman, Beker, Tesi, Morris, Indakoetxea, Collij, Scherer, Morenas-Rodríguez, Ironside, van Berckel, Alcolea, Wiendl, Strickland, Pastor, Rodríguez Rodríguez, , , , , , , Boeve, Petersen, Ferman, van Gerpen, Reinders, Uitti, Tárraga, Maier, Dols-Icardo, Kawalia, Dalmasso, Boada, Zettl, van Schoor, Beekman, Allen, Masliah, de Munain, Pantelyat, Wszolek, Ross, Dickson, Graff-Radford, Knopman, Rademakers, Lemstra, Pijnenburg, Scheltens, Gasser, Chinnery, Hemmer, Huisman, Troncoso, Moreno, Nohr, Sørensen, Heutink, Sánchez-Juan, Posthuma, , Clarimón, Christensen, Ertekin-Taner, Scholz, Ramirez, Ruiz, Slagboom, van der Flier, Holstege (2020) Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity Acta Neuropathol (IF: 12.7) 139(5) 959-962Abstract
The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181435http://www.ncbi.nlm.nih.gov/pubmed/31955222
http://dx.doi.org/10.1007/s00401-019-02107-8